Current issue
Archive
Online first
About the Journal
Editorial Office
Editorial Board
Publisher
Editorial Policies
Ethical standards and procedures
Abstracting and indexing
Reviewers
Honorary Reviewers
Subscription
Contact
Most read articles
Instructions for authors
Article processing charge (APC)
Books and Events
Books
Events
SHORT COMMUNICATION
Early arthritis
Online publication date: 2012-06-01
Reumatologia 2012;50(2):79-82
KEYWORDS
ABSTRACT
In the first 12 weeks of persistence of arthritis symptoms a significant number of patients do not fulfil the criteria for the classification and diagnosis of a specific rheumatic disease. Such cases are recognized under the name of undifferentiated or early arthritis. Patients with early arthritis should be immediately referred to the rheumatologist, whose task is to implement all diagnostic tests necessary to establish, in the shortest possible time, the diagnosis and the presence of prognostic factors for the development of a chronic inflammation (Fig. 1). In case of revealing unfavourable prognostic factors, treatment with disease-modifying antirheumatic drugs (DMARDs) should be started immediately. Methotrexate is a drug of first choice with a dose of 25–30 mg per week recommended. The diagnostic standards for patients with early arthritis have been established in Europe and should be applicable in Poland as well.
REFERENCES (15)
1.
Hazlewood G, Aletaha D, Carmena L, et al. Algorithm for identification of undifferentiated peripheral inflammatory arthritis: a multinational collaboration through the 3e initiative. .
3.
Machado P, Castrejon I, Katchamart W, et al. Multinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative. Ann Rheum Dis 2011; 70: 15-24.
4.
Hueber W, Utz PJ, Robinson WH. Autoantibodies in early arthritis: advances in diagnosis and prognostication. Clin Exp Rheumatol 2003; 21 (suppl 31): 59-64.
5.
Schoels M, Bombardier C, Aletaha D. Diagnostic and prognostic value of antibodies and soluble biomarkers in undifferentiated peripheral inflammatory arthritis: a systematic review. J Rheumatol Suppl 2011; 87: 20-25. .
6.
Millot F, Clavel G, Etchepare F, et al. Musculoskeletal ultrasonography in healthy subjects and ultrasound criteria for early arthritis (the ESPOIR cohort). J Rheumatol 2011; 38: 613-620.
7.
Duer-Jensen A, Hørslev-Petersen K, Hetland ML, et al. Bone edema on magnetic resonance imaging is an independent predictor of rheumatoid arthritis development in patients with early undifferentiated arthritis. Arthritis Rheum 2011; 63: 2192-2202.
8.
Thevissen K, Vercoutere W, Bombardier C, Landewé RB. Diagnostic and prognostic value of synovial biopsy in adult undifferentiated peripheral inflammatory arthritis: a systemic review. J Rheumatol Suppl 2011; 87: 45-47.
9.
Scott DL. The Diagnosis and prognosis of Early Arthritis: Rationale for New Prognostic Criteria. Arthritis Rheum 2002; 46: 286-290.
10.
chumacher HR Jr, Habre W, Meador R, et al. Predictive factors in early arthritis: long-term follow-up. Semin Arthritis Rheum 2004; 33: 264-272.
11.
Saraux A, Berthelot JM, Chalès G, et al. Ability of the American College of Rheumatology 1987 criteria to predict rheumatoid arthritis in patients with early arthritis and classification of these patients two years later. Arthritis Rheum 2001; 44: 2485-2491.
12.
Finckh A. Early inflammatory arthritis versus rheumatoid arthritis. Curr Opin Rheumatol 2009; 21: 118-123. .
13.
Combe B, Landewe R, Lukas C, et al. EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2007; 66: 34-45.
14.
Machold KP, Nell VPK, Stamm TA, et al. Aspects of early arthritis. Traditional DMARD therapy: is it sufficient? Arthritis Res Ther 2006; 8: 211.
15.
Van Dongen H, Van Aken J, Lard LR, et al. Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: A double-blind, randomized, placebo-controlled trial. Arthritis Rheum 2007; 55: 1424-1432.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Share
RELATED ARTICLE
| eISSN: | 2084-9834 |
| ISSN: | 0034-6233 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
